MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks

StemCells to wind down operations after ending mid-stage study

June 2, 2016 By MassDevice Leave a Comment

(Reuters) – StemCells Inc said it would wind down operations after the company terminated a mid-stage trial testing its therapy in spinal cord injury, sending its shares plummeting 85%. The magnitude of the treatment’s effect did not justify continuing the study given the financial resources available, StemCells said on Tuesday. The Newark, California-based biotech said […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: StemCells Inc.

StemCells says spinal injury therapy shows promise

November 20, 2015 By MassDevice Leave a Comment

(Reuters) — StemCells Inc said its experimental stem cell therapy improved the functioning and strength of limbs in patients with spinal cord injuries, becoming the second company to report promising data on the treatment for such injuries. The biotech company said interim results from the mid-stage study showed 4 of 6 patients experienced an improvement on 2 different scales. […]

Filed Under: Clinical Trials, Regenerative Medicine Tagged With: StemCells Inc.

Pluristem launches Phase I clinical trial to treat tendonitis with stem cells

May 17, 2013 By Sony Salzman Leave a Comment

Pluristem Invasive Devices Inc. logo

Pluristem (NSDQ:PSTI) announced a new Phase I clinical trial to treat chronic tendonitis with the company’s PLX-PAD stem cell therapy.

Cell therapy has traditionally been used in cancer and cardiac treatments, but Pluristem is now applying the technology to sports-related injuries, where it has seen an increased interest among athletes and orthopedic surgeons.

Filed Under: News Well, Orthopedics, Stem Cells Tagged With: Aastron Biosciences, Clinical Trials, Geron Corp., InVivo Therapeutics, Pluristem, StemCells Inc.

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS